Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. (IDXX) vs IQVIA Holdings Inc. (IQV)

IDEXX Laboratories, Inc. and IQVIA Holdings Inc. are both Diagnostics & Research companies. IQVIA Holdings Inc. is the larger, with a market value of $45.3B against $40.2B — 1.1× the size. IQVIA Holdings Inc. trades at the lower P/E: 33.3× against 36.2×. IDEXX Laboratories, Inc. grew revenue faster over the last twelve months: 12.8% against 8.17%. IDEXX Laboratories, Inc. has the higher net margin (25.0% vs 8.10%) and the higher return on invested capital (48.9% vs 6.80%). Across the 22 metrics below, IDEXX Laboratories, Inc. leads on 13 and IQVIA Holdings Inc. on 9.

Valuation

Metric IDXX IQV Diagnostics & Research median
P/E 36.24 33.26 33.95
P/S 9.00 2.64 4.87
P/B 25.42 7.13 3.12
Price to free cash flow 33.14 19.88 34.02
EV/EBITDA 25.58 17.27 25.20
EV/Sales 9.06 3.46 5.66
Earnings yield 2.76% 3.01% (1.75%)
Free cash flow yield 3.02% 5.03% (0.13%)

Profitability

Metric IDXX IQV Diagnostics & Research median
Gross margin 62.45% 32.97% 50.89%
Operating margin 32.03% 12.95% (8.57%)
Net margin 25.03% 8.10% (6.37%)
Free cash flow margin 27.17% 13.30% 0.00%
Return on equity 74.21% 22.75% (2.92%)
Return on assets 33.65% 4.70% (6.71%)
Return on invested capital 48.87% 6.80% 0.00%

Growth

Metric IDXX IQV Diagnostics & Research median
Revenue growth (TTM) 12.77% 8.17% 7.69%
EPS growth (last fiscal year) 22.59% 4.67% —
Revenue growth, 5-year CAGR 9.72% 7.50% 7.40%
Net income growth, 5-year CAGR 12.74% 37.27% 0.00%

Health

Metric IDXX IQV Diagnostics & Research median
Debt to equity 0.28 2.54 0.11
Current ratio 1.17 0.71 2.02
Net debt to EBITDA 0.18 4.06 0.78

Dividend

Metric IDXX IQV Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IDXX IQV Diagnostics & Research median
Market cap 40.18b 45.27b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack